73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer, finds UK study

One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer, finds UK study

by University of LeedsCredit: Unsplash/CC0 Public DomainOne in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it

One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer, finds UK study

by University of LeedsCredit: Unsplash/CC0 Public DomainOne in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it
New study shows immigrant adults with liver cancer have higher survival rates than those born in the US

New study shows immigrant adults with liver cancer have higher survival rates than those born in the US

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainImmigrant adults with liver cancer in the United States have higher survival rates than people with the disease who were born in

New study shows immigrant adults with liver cancer have higher survival rates than those born in the US

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainImmigrant adults with liver cancer in the United States have higher survival rates than people with the disease who were born in
Lethal cancer cells buddy up to survive

Lethal cancer cells buddy up to survive

by University of California, IrvineConsistent Metabolic Features in a Second PDA Clonal Cell Model and Media Metabolite Profiling.A. Dose response curves of oligomycin treated KPC clones 28

Lethal cancer cells buddy up to survive

by University of California, IrvineConsistent Metabolic Features in a Second PDA Clonal Cell Model and Media Metabolite Profiling.A. Dose response curves of oligomycin treated KPC clones 28
Tumor macrophage marker offers unique target for treatment

Tumor macrophage marker offers unique target for treatment

by National Institutes of HealthA nanoparticle attached to CRV (CRV-NP) specifically homed to macrophages in breast tumors in mice (yellow arrow) and did not home to spleen, lung or heart. Nanopa

Tumor macrophage marker offers unique target for treatment

by National Institutes of HealthA nanoparticle attached to CRV (CRV-NP) specifically homed to macrophages in breast tumors in mice (yellow arrow) and did not home to spleen, lung or heart. Nanopa
Experts band together to eradicate prostate cancer

Experts band together to eradicate prostate cancer

by Monash UniversityProstate cancer is surprising difficult to keep alive outside the human body. Yet, like a greenhouse full of rare plants, the Melbourne Urological Research Alliance (MURAL) ha

Experts band together to eradicate prostate cancer

by Monash UniversityProstate cancer is surprising difficult to keep alive outside the human body. Yet, like a greenhouse full of rare plants, the Melbourne Urological Research Alliance (MURAL) ha
Test can predict how people with leukaemia will respond to chemotherapy

Test can predict how people with leukaemia will respond to chemotherapy

by BloodwiseCredit: CC0 Public DomainThe first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed at Cardiff

Test can predict how people with leukaemia will respond to chemotherapy

by BloodwiseCredit: CC0 Public DomainThe first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed at Cardiff
Immunotherapy plus an investigational cancer drug improves anti-tumor effects

Immunotherapy plus an investigational cancer drug improves anti-tumor effects

by Duke University Medical CenterCredit: Pixabay/CC0 Public DomainAn investigational therapy for solid tumors could be especially effective when combined with immunotherapy to target a specific k

Immunotherapy plus an investigational cancer drug improves anti-tumor effects

by Duke University Medical CenterCredit: Pixabay/CC0 Public DomainAn investigational therapy for solid tumors could be especially effective when combined with immunotherapy to target a specific k
Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same
Team discovers secret to making immune cells better cancer killers

Team discovers secret to making immune cells better cancer killers

by University of VirginiaResearchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their finding could allow doctors to make the

Team discovers secret to making immune cells better cancer killers

by University of VirginiaResearchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their finding could allow doctors to make the
Treatment to a T? Taking a 'BiTE' out of lung cancer

Treatment to a T? Taking a 'BiTE' out of lung cancer

by Osaka UniversityThe team measured the T-lymphocyte cytotoxicity against tumor cell lines using a molecule that binds to both T lymphocytes and tumor cell lines. Credit: Osaka UniversityImmune

Treatment to a T? Taking a 'BiTE' out of lung cancer

by Osaka UniversityThe team measured the T-lymphocyte cytotoxicity against tumor cell lines using a molecule that binds to both T lymphocytes and tumor cell lines. Credit: Osaka UniversityImmune
Study: Fat cells play key role in dangerous transformation of melanoma

Study: Fat cells play key role in dangerous transformation of melanoma

by Tel Aviv UniversityNano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells, leading to activation of T cells to recognize and attack melanoma. Cr

Study: Fat cells play key role in dangerous transformation of melanoma

by Tel Aviv UniversityNano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells, leading to activation of T cells to recognize and attack melanoma. Cr
Study provides new guidelines for assessing severity of head and neck cancers

Study provides new guidelines for assessing severity of head and neck cancers

by Cedars-Sinai Medical Center'The greater the number of malignant lymph nodes, the less favorable the patients' chances of survival,' said Allen S. Ho, MD. Ho is director of the Head

Study provides new guidelines for assessing severity of head and neck cancers

by Cedars-Sinai Medical Center'The greater the number of malignant lymph nodes, the less favorable the patients' chances of survival,' said Allen S. Ho, MD. Ho is director of the Head